Skip to content

13F-HR filed by SR ONE CAPITAL MANAGEMENT, LP

SR ONE CAPITAL MANAGEMENT, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:06:33 UTC, with 17 holding rows worth $1,149,539,649.

Accession
0001012975-26-001062
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 17 entries on the cover page, a total value of $1,149,539,649 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,149,539,649 with VALUE read as dollars as filed, 13F file number 028-21964. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VERADERMICS INC922967104COMMON STOCK2,080,119$252,172,826dollars as filed
ADARx Pharmaceuticals, Inc.00654F105Common Stock, par value $0.0001 per share9,936,661$198,137,020dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock5,037,854$135,870,922dollars as filed
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock2,038,763$112,784,369dollars as filed
AVALYN PHARMA INC05348Y105COMMON STOCK3,308,649$94,263,410dollars as filed
Odyssey Therapeutics, Inc.67613T104COMMON STOCK3,794,883$84,322,300dollars as filed
DESIGN THERAPEUTICS INC25056L103COM6,526,476$82,037,803dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM4,615,384$62,169,223dollars as filed
MINERALYS THERAPEUTICS INC603170101COM1,563,966$39,302,466dollars as filed
KORSANA BIOSCIENCES INC23255M303COMMON STOCK613,915$19,645,280dollars as filed
MOBIA MED INC60705V103COMMON STOCK1,986,072$18,768,380dollars as filed
ARS PHARMACEUTICALS INC82835W108COM4,012,903$17,295,612dollars as filed
ALUMIS INC022307102COM1,959,896$14,483,631dollars as filed
NKARTA INC65487U108COMMON STOCK3,333,333$8,733,333dollars as filed
OCULIS HOLDING AGH5870P102CMN641,022$5,987,146dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM137,753$2,070,428dollars as filed
ENGENE THERAPEUTICS INC29286X101COM747,750$1,495,500dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-26-001062this filing2026-11-16